Cognitive-behavioral therapy (CBT) works better than placebo and as well or better than fluoxetine for social anxiety disorder (SAD).

Using combination antipsychotic treatment has become more common over the years, presumably reflecting a common sense theory that in refractory patients, two medications might be more effective than one. But studies thus far of the practice have been small and inconclusive.

A long term study comparing patients with early onset psychosis to those with later onset psychosis may have some good news for child psychiatry. While previous studies have shown worse or equivalent outcomes for younger onset patients, this study demonstrated a protective effect.

The overwhelming prevalence of autism and autism spectrum disorders (ASDs) has led to almost countless interventions for children and adolescents with these diagnoses. But do we really have scientific proof that any of them work?

We know that psychotherapy is generally effective for depression, but we don’t really know which depressed patients will respond better than others.

Children and adolescents with tic disorders (TD) very often have comorbid psychiatric diagnoses.

Advocates tout restricted diets for the treatment of everything from migraines to autism.

It’s commonly known across all fields of medicine, psychiatry included, that in clinical trials, placebo treatment works, in some cases just as well as “real” treatment.

SSRIs theoretically work by inhibiting the reuptake of serotonin, presumably by blocking the serotonin transporter pump whose job is to clean up excess serotonin in the synapses between neurons.

What is the best way to help someone quit smoking? A recent trial compared the most popular over-thecounter and prescription treatments to answer this question.